Metformin Does Not Significantly Alter Longitudinal Dynamics of Clonal Hematopoiesis

In our cohorts, duration of metformin use among diabetic users was associated with a small reduction in CH growth rate (-0.06%/year), which is modest compared to typical DNMT3A clonal growth rates of 5-7% annually. Metformin's clinical utility for modulating clonal dynamics in real-world settings appear limited and its clinical use for this indication requires further investigation in prospective studies.

Authors

Institutions

Publication Details

Journal
Clinical Cancer Research
Published
2026-01-28
DOI
https://doi.org/10.1158/1078-0432.ccr-25-3606
Primary Topic
Metabolism, Diabetes, and Cancer
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Metformin Does Not Significantly Alter Longitudinal Dynamics of Clonal Hematopoiesis

Jason Collins, Hind A. Beydoun, Michael C. Honigberg, Rachel S. Heise et al.
Clinical Cancer Research
Metabolism, Diabetes, and Cancer
article

Metformin Does Not Significantly Alter Longitudinal Dynamics of Clonal Hematopoiesis

Jason Collins, Hind A. Beydoun, Michael C. Honigberg, Rachel S. Heise, Siddhartha Jaiswal, Liying Xue, V. M. Glaser, Jacob Otto Kitzman, J. Haessler, Alexander Reiner, Elena Glick, Yash Pershad, Pinkal Desai, Taralynn Mack, Bernhard Haring, Wodan Ling, Pradeep Natarajan, Aladdin Shadyab, Eric A. Whitsel, Alexander G. Bick, Charles Kooperberg, Kun Zhao, Robert Wallace, Caitlyn Vlasschaert, Md Mesbah Uddin, Eshani Pareek, JoAnn E. Manson
article en

Abstract

In our cohorts, duration of metformin use among diabetic users was associated with a small reduction in CH growth rate (-0.06%/year), which is modest compared to typical DNMT3A clonal growth rates of 5-7% annually. Metformin's clinical utility for modulating clonal dynamics in real-world settings appear limited and its clinical use for this indication requires further investigation in prospective studies.

Clinical Cancer Research
Broad Institute (US), University of North Carolina at Chapel Hill (US), University of Iowa (US), University of Washington (US), Queen's University (CA), Cornell University (US), University of Michigan (US), Fred Hutch Cancer Center (US), Presbyterian Hospital (US), Iowa Department of Public Health (US), Human Longevity (United States) (US), University of Washington Applied Physics Laboratory (US), Department of Veterans Affairs (AU), University of North Carolina System (US), Mass General Brigham (US), Vanderbilt University Medical Center (US), Saarland University (DE), The University of Texas Health Science Center at Houston (US), Stanford University (US)
Openalex Percentile: Top 75%
Metabolism, Diabetes, and Cancer
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.